336 related articles for article (PubMed ID: 28601286)
21. Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies.
Vallat JM; Yuki N; Sekiguchi K; Kokubun N; Oka N; Mathis S; Magy L; Sherman DL; Brophy PJ; Devaux JJ
Neuromuscul Disord; 2017 Mar; 27(3):290-293. PubMed ID: 27986399
[TBL] [Abstract][Full Text] [Related]
22. Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti-Neurofascin-155 Antibodies.
Bailly L; Mongin M; Delorme C; Apartis E; Saheb S; Viala K; Roze E
Tremor Other Hyperkinet Mov (N Y); 2018; 8():606. PubMed ID: 30619643
[TBL] [Abstract][Full Text] [Related]
23. [Autoantibodies in Chronic Inflammatory Demyelinating Polyneuropathy].
Koga M
Brain Nerve; 2018 Apr; 70(4):395-403. PubMed ID: 29632287
[TBL] [Abstract][Full Text] [Related]
24. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
[TBL] [Abstract][Full Text] [Related]
25. IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay.
Kadoya M; Kaida K; Koike H; Takazaki H; Ogata H; Moriguchi K; Shimizu J; Nagata E; Takizawa S; Chiba A; Yamasaki R; Kira JI; Sobue G; Ikewaki K
J Neuroimmunol; 2016 Dec; 301():16-22. PubMed ID: 27852440
[TBL] [Abstract][Full Text] [Related]
26. Nodal-paranodal antibodies in HIV-immune mediated radiculo-neuropathies: Clinical phenotypes and relevance.
Moodley K; Patel VB; Moodley AA; Bill PLA; Kajee A; Mgbachi V; Fehmi J; Rinaldi S
J Peripher Nerv Syst; 2023 Dec; 28(4):578-585. PubMed ID: 37676746
[TBL] [Abstract][Full Text] [Related]
27. Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy.
Doppler K; Appeltshauser L; Villmann C; Martin C; Peles E; Krämer HH; Haarmann A; Buttmann M; Sommer C
Brain; 2016 Oct; 139(Pt 10):2617-2630. PubMed ID: 27474220
[TBL] [Abstract][Full Text] [Related]
28. Neurofascin-155 IgM autoantibodies in patients with inflammatory neuropathies.
Doppler K; Stengel H; Appeltshauser L; Grosskreutz J; Man Ng JK; Meinl E; Sommer C
J Neurol Neurosurg Psychiatry; 2018 Nov; 89(11):1145-1151. PubMed ID: 29945879
[TBL] [Abstract][Full Text] [Related]
29. Chronic Inflammatory Demyelinating Polyneuropathy With Concurrent Membranous Nephropathy: An Anti-paranode and Podocyte Protein Antibody Study and Literature Survey.
Hashimoto Y; Ogata H; Yamasaki R; Sasaguri T; Ko S; Yamashita K; Xu Z; Matsushita T; Tateishi T; Akiyama S; Maruyama S; Yamamoto A; Kira JI
Front Neurol; 2018; 9():997. PubMed ID: 30538665
[No Abstract] [Full Text] [Related]
30. Characterization of the patients with antibodies against nodal-paranodal junction proteins in chronic inflammatory demyelinating polyneuropathy.
Dong M; Tai H; Yang S; Gao X; Pan H; Zhang Z
Clin Neurol Neurosurg; 2022 Dec; 223():107521. PubMed ID: 36401951
[TBL] [Abstract][Full Text] [Related]
31. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
Shelly S; Klein CJ; Dyck PJB; Paul P; Mauermann ML; Berini SE; Howe B; Fryer JP; Basal E; Bakri HM; Laughlin RS; McKeon A; Pittock SJ; Mills J; Dubey D
Neurology; 2021 Dec; 97(24):e2392-e2403. PubMed ID: 34635556
[TBL] [Abstract][Full Text] [Related]
32. Antibodies against peripheral nerve antigens in chronic inflammatory demyelinating polyradiculoneuropathy.
Querol L; Siles AM; Alba-Rovira R; Jáuregui A; Devaux J; Faivre-Sarrailh C; Araque J; Rojas-Garcia R; Diaz-Manera J; Cortés-Vicente E; Nogales-Gadea G; Navas-Madroñal M; Gallardo E; Illa I
Sci Rep; 2017 Oct; 7(1):14411. PubMed ID: 29089585
[TBL] [Abstract][Full Text] [Related]
33. Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy.
Ogata H; Isobe N; Zhang X; Yamasaki R; Fujii T; Machida A; Morimoto N; Kaida K; Masuda T; Ando Y; Kuwahara M; Kusunoki S; Nakamura Y; Matsushita T; Kira JI
J Neuroimmunol; 2020 Feb; 339():577139. PubMed ID: 31864140
[TBL] [Abstract][Full Text] [Related]
34. Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment.
Garg N; Park SB; Yiannikas C; Vucic S; Howells J; Noto YI; Mathey EK; Pollard JD; Kiernan MC
Muscle Nerve; 2018 May; 57(5):848-851. PubMed ID: 29130507
[TBL] [Abstract][Full Text] [Related]
35. Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP).
Klehmet J; Märschenz S; Ruprecht K; Wunderlich B; Büttner T; Hiemann R; Roggenbuck D; Meisel A
Clin Chem Lab Med; 2018 May; 56(6):919-926. PubMed ID: 29329103
[TBL] [Abstract][Full Text] [Related]
36. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.
Querol L; Devaux J; Rojas-Garcia R; Illa I
Nat Rev Neurol; 2017 Sep; 13(9):533-547. PubMed ID: 28708133
[TBL] [Abstract][Full Text] [Related]
38. Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo.
Manso C; Querol L; Lleixà C; Poncelet M; Mekaouche M; Vallat JM; Illa I; Devaux JJ
J Clin Invest; 2019 Mar; 129(6):2222-2236. PubMed ID: 30869655
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis.
Yan W; Nguyen T; Yuki N; Ji Q; Yiannikas C; Pollard JD; Mathey EK
J Neuroimmunol; 2014 Dec; 277(1-2):13-7. PubMed ID: 25262157
[TBL] [Abstract][Full Text] [Related]
40. Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.
Burnor E; Yang L; Zhou H; Patterson KR; Quinn C; Reilly MM; Rossor AM; Scherer SS; Lancaster E
Neurology; 2018 Jan; 90(1):e31-e38. PubMed ID: 29187518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
